全球寡核苷酸合成市場規模、佔有率、成長分析，依最終用途（學術研究機構、診斷實驗室）、依應用（PCR 引子、PCR 檢測和麵板）- 2024-2031 年產業預測

Global Oligonucleotide Synthesis Market Size, Share, Growth Analysis, By End-use(Academic Research Institutes, Diagnostic Laboratories), By Application(PCR Primers, PCR Assays and Panels) - Industry Forecast 2024-2031

出版日期: 2024年04月07日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球寡核苷酸合成市場規模為46.0億美元，預計將從2023年的51.6億美元成長到2031年的128.6億美元，預測期間（2024-2031年）複合年成長率為12.10%。

寡核苷酸合成市場透過提供用於各種目的的客製化和預製寡核苷酸來滿足研究人員、科學家和製造商的需求，包括基因合成、PCR、DNA 定序、診斷和治療。該市場的主要驅動力是在基因研究進步的推動下，對合成生物學和個人化醫療的需求不斷成長。此外，癌症和遺傳性疾病發生率的增加也促進了市場的成長。然而，寡核苷酸合成市場面臨確保品質控制、遵守監管標準以及解決與基因合成相關的倫理問題等課題。此外，寡核苷酸合成日益複雜以及對專業設備和專業知識的需求為市場參與者帶來了重大障礙。儘管有這些課題，市場仍提供創新機會，包括開發新的合成技術和擴大寡核苷酸的應用領域。此外，對個人化醫療和基因治療的需求不斷成長，為市場擴張創造了途徑。總體而言，雖然寡核苷酸合成市場有望持續成長，但它可能會遇到與成本、技術熟練程度、品質保證和監管合規性相關的障礙。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

Agilent Technologies, Inc. (US)
BioAutomation Corporation (US)
Biosearch Technologies, Inc. (US)
Biolytic Lab Performance Inc. (Canada)
Eurofins Genomics LLC (US)
General Electric Company (US)
GenScript Biotech Corporation (China)
Integrated DNA Technologies, Inc. (US)
Kaneka Eurogentec SA (Belgium)
LGC Limited (UK)
Merck KGaA (Germany)
Nitto Denko Avecia Inc. (US)
Thermo Fisher Scientific Inc. (US)
TriLink BioTechnologies, LLC (US)
Twist Bioscience Corporation (US)
ATDBio Ltd. (UK)
Axil Scientific Pte Ltd. (Singapore)
Biogen International GmbH (Switzerland)
Biomer Technology LLC (US)
Bio-Synthesis, Inc. (US)

簡介目錄

Product Code: SQMIG35H2107

Global oligonucleotide synthesis market size was valued at USD 4.60 billion in 2022 and is poised to grow from USD 5.16 billion in 2023 to USD 12.86 billion by 2031, at a CAGR of 12.10% during the forecast period (2024-2031).

The oligonucleotide synthesis market serves the needs of researchers, scientists, and manufacturers by offering customized and pre-manufactured oligonucleotides for various purposes, including gene synthesis, PCR, DNA sequencing, diagnostics, and therapeutics. A primary driver of this market is the rising demand for synthetic biology and personalized medicine, fueled by advancements in genetic research. Additionally, the growing incidence of cancer and genetic disorders contributes to the market's growth. However, the oligonucleotide synthesis market encounters challenges such as ensuring quality control, adhering to regulatory standards, and addressing ethical concerns related to gene synthesis. Moreover, the increasing complexity of oligonucleotide synthesis and the requirement for specialized equipment and expertise present significant hurdles for market participants. Despite these challenges, the market offers opportunities for innovation, including the development of new synthesis technologies and expanding the application areas for oligonucleotides. Furthermore, the rising demand for personalized medicine and gene therapy creates avenues for market expansion. Overall, while the oligonucleotide synthesis market is poised for continued growth, it may encounter obstacles related to cost, technical proficiency, quality assurance, and regulatory compliance.

Top-down and bottom-up approaches were used to estimate and validate the size of the global oligonucleotide synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oligonucleotide Synthesis Market Segmental Analysis

The global oligonucleotide synthesis market is segmented based on end-use, application, and region. By end-use, the market is segmented into academic research institutes, diagnostic laboratories, and pharmaceutical - biotechnology companies. By application, the market is segmented into PCR primers, PCR assays and panels, sequencing, DNA microarrays, fluorescence in situ hybridization (FISH), Antisense oligonucleotides, and other applications. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Oligonucleotide Synthesis Market

The global oligonucleotide synthesis market is being propelled by the increasing need for oligonucleotides in drug development and diagnostics. Oligonucleotides such as PCR primers, antisense oligonucleotides, and siRNA are extensively utilized in these fields, contributing to the market's growth.

Restraints in the Global Oligonucleotide Synthesis Market

The oligonucleotide synthesis market faces a notable hurdle due to the high cost associated with the synthesis process. This complexity necessitates specialized equipment and expertise, thereby increasing the manufacturing expenses for oligonucleotides.

Market Trends of the Global Oligonucleotide Synthesis Market

The demand for tailored oligonucleotides has been on the rise, catering to specific applications in fields like research, diagnostics, and therapeutics. This trend is driven by the expanding utilization of oligonucleotides in drug development, genetic testing, and personalized medicine. Integrated DNA Technologies, a prominent supplier of customized oligonucleotides, exemplifies this trend by offering a diverse array of oligonucleotides tailored for various research, diagnostic, and therapeutic purposes.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Oligonucleotide Synthesis Market by End-use

Market Overview
Academic Research Institutes
Diagnostic Laboratories
Pharmaceutical Biotechnology Companies

Global Oligonucleotide Synthesis Market by Application

Market Overview
PCR Primers
PCR Assays and Panels
Sequencing
DNA Microarrays
Fluorescence in Situ Hybridization (FISH)
Antisense Oligonucleotides
and Other Applications

Global Oligonucleotide Synthesis Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioAutomation Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosearch Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biolytic Lab Performance Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Genomics LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
General Electric Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integrated DNA Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaneka Eurogentec S.A. (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGC Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nitto Denko Avecia Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TriLink BioTechnologies, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Twist Bioscience Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ATDBio Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Axil Scientific Pte Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogen International GmbH (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomer Technology LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Synthesis, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments